News | Radiology Business | December 16, 2020

Radiology Partners Completes Acquisition of Mednax Radiology Solutions

Combined expertise and experience brings opportunity for unmatched innovation and clinical value to radiology

Radiology Partners (RP), a leading radiology practice in the U.S., announced the completion of its acquisition of Mednax Radiology Solutions, a division of Mednax, Inc., in a transaction valued at approximately $885 million

December 16, 2020 — Radiology Partners (RP), a leading radiology practice in the U.S., announced the completion of its acquisition of Mednax Radiology Solutions, a division of Mednax, Inc., in a transaction valued at approximately $885 million. Following all necessary regulatory approvals — including the Federal Trade Commission’s (FTC) Hart-Scott Rodino (HSR) antitrust review process and other customary closing conditions — the acquisition closed and became effective December 15.

“This is a significant chapter in the history of our Practice, and we are thrilled to welcome hundreds of Mednax radiologists and support team members to the RP family,” said Rich Whitney, RP Chairman and CEO. “Together, we will continue to elevate radiologists’ role in our healthcare system as we advance our mission to transform radiology. We look forward to expanded and meaningful collaboration in the areas of clinical innovation, subspecialty coverage, advanced technology and growth opportunities.”

The combination of RP and Mednax Radiology Solutions — two of the country’s leading radiology teams — totals more than 2,400 radiologists. Mednax announced its intent to divest its radiology division in June 2020. For the past several years, including throughout the pandemic environment of 2020, RP has exhibited an ability to grow successfully and to further advance its mission to transform radiology.

“Since RP’s intent was announced in September, we’ve thought a great deal about how a combined Practice will enhance our capabilities for clinical care,” said Ricardo C. Cury, M.D., FACR, Chief Medical Officer of Mednax Radiology Solutions. “With the deal’s completion, it’s now time to roll up our sleeves and get to work on creating new pathways for innovation, leveraging our combined strengths and, ultimately, improving patient care.”

The combination of RP and Mednax Radiology solutions will extend coverage into new areas while also expanding coverage in existing areas. Together, the organizations have greater resources for large-scale clinical programs and technology solutions, enabling radiologist leaders across the organization to advance RP’s mission to transform radiology.

For more information: www.radpartners.comwww.mednax.com.

Related Content

MRI of Nonferromagnetic Ballistics Suspended in Gelatin. 

MRI of Nonferromagnetic Ballistics Suspended in Gelatin. Scout (A), T1-weighted spin-echo (SE) (B), T2-weighted SE (C), T2-weighted gradient-recalled echo (GRE) (TR/TE, 500/10; D), and T2-weighted GRE (TR/TE, 700/30; E) MR images show jacket hollow point .45 automatic Colt pistol bullet (Corbon) (1), solid lead .45 Long Colt bullet (Winchester) (2), full metal jacket (FMJ) automatic Colt pistol bullet (Winchester) (3), 5.56-mm FMJ bullet (Federal Ammunition) (4), #7 lead shotgun pellet (Winchester) (5), and 5-mm lead air gun pellet (Sheridan) (6). On all sequences, metallic artifact is minimal. Although metallic artifact increases or blooms with increased TR/TE in GRE images (D and E), amount of surrounding distortion is still minimal.

News | Magnetic Resonance Imaging (MRI) | January 15, 2021
January 15, 2021 — 
Novel Coronavirus SARS-CoV-2 Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: National Institute of Allergy and Infectious Diseases, NIH

Novel Coronavirus SARS-CoV-2 Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Image courtesy of  National Institute of Allergy and Infectious Diseases (NIH)

News | Coronavirus (COVID-19) | January 15, 2021
January 15, 2021 — In one of the first studies to examine the impact of the...
Multidisciplinary functionality supports high-capacity utilization and economic efficiency
News | Mobile C-Arms | January 14, 2021
January 14, 2021 — Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the...
Use of telehealth jumped sharply during the first months of the coronavirus pandemic shutdown, with the approach being used more often for behavioral health services than for medical care, according to a new RAND Corporation study.

Getty Images

News | Teleradiology | January 13, 2021
January 13, 2021 — Use of telehealth jumped sha
The U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach to advance the Agency's oversight of AI/ML-based medical software.
News | Artificial Intelligence | January 12, 2021
January 12, 2021 — The U.S.
Myocarditis among recovering COVID-19 athletes less common than previously reported

Getty Images

News | Cardiac Imaging | January 11, 2021
January 11, 2021 — In a letter published in the December issue of the American Heart Association's...
Jeff Elias, MD, is a neurosurgeon at UVA Health and a pioneer in the field of focused ultrasound.

Jeff Elias, MD, is a neurosurgeon at UVA Health and a pioneer in the field of focused ultrasound. Image courtesy of UVA Health

News | Focused Ultrasound Therapy | January 08, 2021
January 8, 2021 — A scalpel-free alternative to brain surgery has the potential to benefit people with...
The FDA is monitoring the potential impact of viral mutations, including an emerging variant from the United Kingdom known as the B.1.1.7 variant, on authorized SARS-CoV-2 molecular tests

Getty Images

News | Coronavirus (COVID-19) | January 08, 2021
January 8, 2021 — The U.S.
Mirion Technologies, Inc., a global provider of innovative radiation detection and measurement solutions, announced that it has acquired Sun Nuclear Corporation. Sun Nuclear is the global leader in radiation oncology quality assurance, delivering patient safety solutions for diagnostic imaging and radiation therapy centers around the world.
News | Quality Assurance (QA) | January 08, 2021
January 8, 2021 — Mirion Technologies, Inc., a global provider of